ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

OpenAI researcher Miles Wang is leaving the company to start an AI drug discovery startup. He is in talks to raise about $200 million at a $2 billion valuation, with Lightspeed in discussions to lead the round. Several other OpenAI researchers are expected to join the new company.
Tap to vote and see what everyone thinks.
Summary by ByteBrief